Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Multifactorial Intervention in Type 2 Diabetes - Italy (MINDIT)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Italian Society of Diabetology
AstraZeneca
Daiichi Sankyo Inc.
Information provided by:
University of Parma
ClinicalTrials.gov Identifier:
NCT01240070
First received: November 12, 2010
Last updated: August 11, 2011
Last verified: October 2010